<DOC>
	<DOCNO>NCT00047476</DOCNO>
	<brief_summary>To evaluate efficacy dexmethylphenidate ( d-MPH ) treatment chemotherapy-related fatigue adult cancer subject .</brief_summary>
	<brief_title>D-MPH Treatment Fatigue Neurobehavioral Function Related Chemotherapy Adult Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Dexmethylphenidate Hydrochloride</mesh_term>
	<criteria>Diagnosis cancer , exclude primary metastatic brain tumor . Treated minimum four cycle cytotoxic chemotherapy , last chemotherapy treatment must complete least 2 month prior study entry . Physical/neurological examination consistent absence focal neurological deficit Women childbearing potential ( WCBP ) must negative serum urine pregnancy test . In addition , sexually active WCBP must agree use adequate contraceptive method ( oral , injectable , implantable hormonal contraceptive ; tubal ligation ; intrauterine device ; barrier contraceptive spermicide ; vasectomized partner ) . Subjects must able adhere protocol requirement . Subjects must understand voluntarily sign informed consent document . Subjects must native English speaker fluent English , least eighth grade education .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2004</verification_date>
	<keyword>neurobehavioral function</keyword>
	<keyword>chemobrain</keyword>
	<keyword>chemo brain</keyword>
	<keyword>fatigue</keyword>
	<keyword>memory loss</keyword>
	<keyword>exhaust</keyword>
	<keyword>trouble concentrate</keyword>
</DOC>